We use cookies to understand how you use our site and to improve your experience.
This includes personalizing content and advertising.
By pressing "Accept All" or closing out of this banner, you consent to the use of all cookies and similar technologies and the sharing of information they collect with third parties.
You can reject marketing cookies by pressing "Deny Optional," but we still use essential, performance, and functional cookies.
In addition, whether you "Accept All," Deny Optional," click the X or otherwise continue to use the site, you accept our Privacy Policy and Terms of Service, revised from time to time.
You are being directed to ZacksTrade, a division of LBMZ Securities and licensed broker-dealer. ZacksTrade and Zacks.com are separate companies. The web link between the two companies is not a solicitation or offer to invest in a particular security or type of security. ZacksTrade does not endorse or adopt any particular investment strategy, any analyst opinion/rating/report or any approach to evaluating individual securities.
If you wish to go to ZacksTrade, click OK. If you do not, click Cancel.
Pro-Dex Stock Skyrockets Over the Past Year: A Must Buy?
Read MoreHide Full Article
Pro-Dex, Inc. (PDEX - Free Report) has witnessed rapid growth over the past year. The company’s valuation has grown tremendously over the period and is currently at an all-time high.
Pro-Dex, founded in 1978 and headquartered in Irvine, CA, also has operations in Santa Ana, Beaverton, OR and Carson City, NV and specializes in speeding up developing and manufacturing tech-based solutions. These include embedded motion control, miniature rotary drive systems and fractional horsepower DC motors, serving the medical, dental, semi-conductor, scientific research and aerospace markets.
Pro-Dex is a Zacks Rank #1 (Strong Buy) company and is part of the Zacks Medical – Dental Supplies industry. McKesson Corporation (MCK - Free Report) and CONMED Corporation (CNMD - Free Report) are two of its peers from the same industry. While McKesson is also ranked #1, CONMED currently carries a Rank #2 (Buy). Over the past 12 months, Pro-Dex has surged 193.8% compared with a 171.8% rally of its Zacks Peer Group. You can see the complete list of today’s Zacks #1 Rank (Strong Buy) stocks here.
Image Source: Zacks Investment Research
The company indeed has been on a growth drive over the last five years, with its share price having increased 239.7% over this period. During these five years, Pro-Dex achieved compound earnings per share growth of 11% per year, suggesting that investors hold the company in high regard. On Jan. 6, the company’s shares soared 23% to $57.78, in what can only be dubbed as a remarkable show of confidence by market participants.
At the end of October, PDEX reported first-quarter fiscal 2025 earnings of 75 cents per share which widely surpassed the Zacks Consensus Estimate of 29 cents. For the company’s next release scheduled on Feb. 13, 2025, we expect earnings of 38 cents per share, indicating a year-over-year increase of 171.43%.
It will thus be prudent to bet on Pro-Dex, which is reasonably valued at around $55, and is likely to be boosted further on a very positive outlook. The Medical – Dental Supplies industry itself is in the top 10% of all industries in the Zacks universe, and that too must also be considered while making an investment decision.
See More Zacks Research for These Tickers
Normally $25 each - click below to receive one report FREE:
Image: Bigstock
Pro-Dex Stock Skyrockets Over the Past Year: A Must Buy?
Pro-Dex, Inc. (PDEX - Free Report) has witnessed rapid growth over the past year. The company’s valuation has grown tremendously over the period and is currently at an all-time high.
Pro-Dex, founded in 1978 and headquartered in Irvine, CA, also has operations in Santa Ana, Beaverton, OR and Carson City, NV and specializes in speeding up developing and manufacturing tech-based solutions. These include embedded motion control, miniature rotary drive systems and fractional horsepower DC motors, serving the medical, dental, semi-conductor, scientific research and aerospace markets.
Pro-Dex is a Zacks Rank #1 (Strong Buy) company and is part of the Zacks Medical – Dental Supplies industry. McKesson Corporation (MCK - Free Report) and CONMED Corporation (CNMD - Free Report) are two of its peers from the same industry. While McKesson is also ranked #1, CONMED currently carries a Rank #2 (Buy). Over the past 12 months, Pro-Dex has surged 193.8% compared with a 171.8% rally of its Zacks Peer Group. You can see the complete list of today’s Zacks #1 Rank (Strong Buy) stocks here.
Image Source: Zacks Investment Research
The company indeed has been on a growth drive over the last five years, with its share price having increased 239.7% over this period. During these five years, Pro-Dex achieved compound earnings per share growth of 11% per year, suggesting that investors hold the company in high regard. On Jan. 6, the company’s shares soared 23% to $57.78, in what can only be dubbed as a remarkable show of confidence by market participants.
At the end of October, PDEX reported first-quarter fiscal 2025 earnings of 75 cents per share which widely surpassed the Zacks Consensus Estimate of 29 cents. For the company’s next release scheduled on Feb. 13, 2025, we expect earnings of 38 cents per share, indicating a year-over-year increase of 171.43%.
It will thus be prudent to bet on Pro-Dex, which is reasonably valued at around $55, and is likely to be boosted further on a very positive outlook. The Medical – Dental Supplies industry itself is in the top 10% of all industries in the Zacks universe, and that too must also be considered while making an investment decision.